Paper316744
Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.
Evans WE and 4 others. Cancer Chemother Pharmacol, 1979. Cited by 113 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients. Papers, record 316744. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/316744
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Methotrexate | Major topic |
| Bone Neoplasms | |
| Drug Therapy, Combination | |
| Half-Life | |
| Humans | |
| Kinetics | |
| Leucovorin | |
| Osteosarcoma | |
| Risk | |
| Time Factors |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 832268 | The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion. | Cancer Res | 1977 | https://conductscience.org/library/papers/832268 | PubMed |
| 2 | 304763 | High-dose methotrexate, not a conventional treatment. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/304763 | PubMed |
| 3 | 5573769 | Methotrexate tissue distribution: prediction by a mathematical model. | J Natl Cancer Inst | 1971 | https://conductscience.org/library/papers/5573769 | PubMed |
| 4 | 884693 | Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity. | Cancer Treat Rep | 1977 | https://conductscience.org/library/papers/884693 | PubMed |
| 5 | 301662 | "Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment. | Semin Oncol | 1977 | https://conductscience.org/library/papers/301662 | PubMed |
| 6 | 301783 | Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration. | Cancer Treat Rep | 1977 | https://conductscience.org/library/papers/301783 | PubMed |
| 7 | 1175171 | Kinetic model for the disposition and metabolism of moderate and high-dose methotrexate (NSC-740) in man. | Cancer Chemother Rep | 1975 | https://conductscience.org/library/papers/1175171 | PubMed |
| 8 | 306284 | Serum distribution of citrovorum factor and 5-methyltetrahydrofolate following oral and im administration of calcium leucovorin in normal adults. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/306284 | PubMed |
| 9 | 305823 | "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/305823 | PubMed |
| 10 | 5127083 | Methotrexate pharmacokinetics. | J Pharm Sci | 1971 | https://conductscience.org/library/papers/5127083 | PubMed |
| 11 | 304376 | Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue. | Cancer Treat Rep | 1977 | https://conductscience.org/library/papers/304376 | PubMed |
| 12 | 304375 | Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models. | Cancer Res | 1978 | https://conductscience.org/library/papers/304375 | PubMed |
| 13 | 4547680 | Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors. | Cancer Res | 1974 | https://conductscience.org/library/papers/4547680 | PubMed |
| 14 | 19151 | Recovery from toxicity associated with high-dose methotrexate: prognostic factors. | Cancer Treat Rep | 1977 | https://conductscience.org/library/papers/19151 | PubMed |
| 15 | 1086423 | High dose methotrexate therapy of solid tumors: observations relating to clinical toxicity. | Med Pediatr Oncol | 1976 | https://conductscience.org/library/papers/1086423 | PubMed |
| 16 | 5073303 | Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion pattern. | Eur J Cancer (1965) | 1972 | https://conductscience.org/library/papers/5073303 | PubMed |
| 17 | 4536622 | Effective absorption and utilization of oral formyltetrahydrofolate in man. | N Engl J Med | 1972 | https://conductscience.org/library/papers/4536622 | PubMed |
| 18 | 4843162 | Relative toxicity of methotrexate in several tissues of mice bearing Lewis lung carcinoma. | J Pharmacol Exp Ther | 1974 | https://conductscience.org/library/papers/4843162 | PubMed |
| 19 | 1087180 | The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides. | Cancer Res | 1976 | https://conductscience.org/library/papers/1087180 | PubMed |
| 20 | 618710 | Effect of pleural effusion on high-dose methotrexate kinetics. | Clin Pharmacol Ther | 1978 | https://conductscience.org/library/papers/618710 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42323774 | Toxicity-Tailored Thresholds of Delayed Methotrexate Elimination in Non-Hodgkin Lymphoma: A Population-Based Approach to Therapy Optimization. | Eur J Drug Metab Pharmacokinet | 2026 | https://conductscience.org/library/papers/42323774 | PubMed |
| 42312165 | A Minimally Invasive, Subcutaneous Biosensor Reliably Estimates Plasma Methotrexate Exposure and Quantifies Plasma-to-Tissue Transport Kinetics. | ACS Pharmacol Transl Sci | 2026 | https://conductscience.org/library/papers/42312165 | PubMed |
| 42243443 | A Model-Informed Early Prediction of Methotrexate-Induced Acute Kidney Injury in Pediatric Patients with Osteosarcoma Using Real-World Data: A Multi-center Pharmacokinetic Study. | Clin Pharmacokinet | 2026 | https://conductscience.org/library/papers/42243443 | PubMed |
| 39640903 | Accidental methotrexate overdose leading to multisystem toxicity: A case report. | Toxicol Rep | 2024 | https://conductscience.org/library/papers/39640903 | PubMed |
| 38026729 | Low serum level and chronic toxicity for methotrexate. Case Report. | Qatar Med J | 2023 | https://conductscience.org/library/papers/38026729 | PubMed |
| 34147089 | Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients. | BMC Cancer | 2021 | https://conductscience.org/library/papers/34147089 | PubMed |
| 33655525 | Lack of drug interaction between levetiracetam and high-dose methotrexate in patients with lymphoma. | Pharmacotherapy | 2021 | https://conductscience.org/library/papers/33655525 | PubMed |
| 32535662 | High-dose methotrexate in ICU patients: a retrospective study. | Ann Intensive Care | 2020 | https://conductscience.org/library/papers/32535662 | PubMed |
| 32090349 | Comparison of Body Size, Morphomics, and Kidney Function as Covariates of High-Dose Methotrexate Clearance in Obese Adults with Primary Central Nervous System Lymphoma. | Pharmacotherapy | 2020 | https://conductscience.org/library/papers/32090349 | PubMed |
| 31657864 | Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours. | Br J Clin Pharmacol | 2020 | https://conductscience.org/library/papers/31657864 | PubMed |
| 31308758 | Identifying risk factors for high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/31308758 | PubMed |
| 27496039 | Preventing and Managing Toxicities of High-Dose Methotrexate. | Oncologist | 2016 | https://conductscience.org/library/papers/27496039 | PubMed |
| 27104192 | Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma. | Blood Res | 2016 | https://conductscience.org/library/papers/27104192 | PubMed |
| 24859553 | The utility of online haemodiafiltration in methotrexate poisoning. | BMJ Case Rep | 2014 | https://conductscience.org/library/papers/24859553 | PubMed |
| 23760811 | Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments. | Cancer Chemother Pharmacol | 2013 | https://conductscience.org/library/papers/23760811 | PubMed |
| 21192315 | Evaluating performance of a decision support system to improve methotrexate pharmacotherapy in children and young adults with cancer. | Ther Drug Monit | 2011 | https://conductscience.org/library/papers/21192315 | PubMed |
| 17115148 | Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation. | Eur J Clin Pharmacol | 2007 | https://conductscience.org/library/papers/17115148 | PubMed |
| 12403645 | Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcoma. | Clin Pharmacokinet | 2002 | https://conductscience.org/library/papers/12403645 | PubMed |
| 10803455 | Adaptive control methods for the dose individualisation of anticancer agents. | Clin Pharmacokinet | 2000 | https://conductscience.org/library/papers/10803455 | PubMed |
| 8306417 | Pharmacokinetics of high-dose methotrexate in adult osteogenic sarcoma. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8306417 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/316744
GET https://conductscience.org/api/papers/v1/316744/references?page=2